A diversity of knowledge & disciplines

Our strong advisor and partner network brings together the best and brightest across sectors to develop the groundbreaking NGP technology ready to transform the treatment of Infectious Diseases.

Clinical

Commercial

Scientific

Stewardship

Network
From above anonymous coworkers reading and signing documents while gathering around table and working on project in office

Steadfast support

Selux Diagnostics is supported by a successful public and private sector collaboration to solve one of the world's toughest health challenges.

NIH logo
Schooner Capital Logo
Sands Capital Ventures Logo
Barda Logo
RA Capital Logo
Northpond Logo

Selux Diagnostics NGP platform has received a total of $30.4 million in funding from the U.S. Department of Health and Human Services (HHS); Office of the Assistant Secretary for Preparedness and Response (ASPR); and the Biomedical Advanced Research and Development Authority (BARDA)

 

Acknowledgment: This platform has been funded in whole or part with federal funds from the U.S. Department of Health and Human Services (HHS); Office of the Assistant Secretary for Preparedness and Response (ASPR); and the Biomedical Advanced Research and Development Authority (BARDA), under Contract No. HHSO100201800013C.